Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease

Figure 5

The expression of serum miR-200c and miR-371-5p in KD patients undergoing the therapy; IVIG: IVIG therapy; ADT: additional drug treatments; PE: plasma exchange; Good-IVIG: KD patients with a good response to IVIG therapy; No-IVIG: KD patients with no response to IVIG therapy; No-IVIG and NNPE: KD patients with no response to IVIG therapy and not needing plasma exchange; NPE: KD patients needing plasma exchange; value < 0.01, paired -test.

(a)

(b)

(c)

(d)

(e)

(f)